Monoclonal Antibody Shows Promise in Mixed Dyslipidemia
MILAN — A single dose of a monoclonal antibody against an inhibitor of an enzyme involved in triglyceride degradation appears to substantially lower triglyceride and […]
Read moreMILAN — A single dose of a monoclonal antibody against an inhibitor of an enzyme involved in triglyceride degradation appears to substantially lower triglyceride and […]
Read moreScientists have long known that cocaine works by latching on to molecular connectors on the surface of brain cells, allowing dopamine, a chemical that promotes […]
Read moreWe are up on the third floor of the electrical building at NTNU, not a place you usually associate with cancer research and medical equipment. […]
Read moreColorado’s COVID-19 hospitalizations jumped 38% this week, and a rise in positive tests showed last week’s slowdown in confirmed new cases was a just blip. […]
Read moreRobin Bolduc isn’t the type of person who takes “no” for an answer — particularly when it comes to fixing her husband’s wheelchair. Her husband, […]
Read moreAromatherapy reduces post-surgical opioid use by half in hip replacement patients anxious before their operation, according to a new preliminary study being presented at the […]
Read moreA research collaboration including scientists from Oregon State University has developed a new technology to help surgeons know where a patient's nerves are, lessening the […]
Read moreHeidi Montag and Spencer Pratt revealed that they are expecting baby number two! The couple, who already have a 4-year-old son named Gunner, broke the […]
Read moreBlocking an immune response-related enzyme holds promise in preventing or treating severe COVID-19 symptoms by reducing inflammation, tissue injury and blood clots in the lungs, […]
Read moreToday, the US Food and Drug Administration (FDA) announced it has withdrawn approval of the lymphoma drug umbralisib (Ukoniq) following an investigation into a “possible […]
Read more